Neuroleptic-induced Movement Disorders in a Naturalistic Schizophrenia Population: Diagnostic Value of Actometric Movement Patterns

Overview

Journal BMC Neurol

Publisher Biomed Central

Specialty Neurology

Date 2008 Apr 19

PMID 18419829

Citations 9

Authors

Sven Janno

Matti M Holi

Katinka Tuisku

Kristian Wahlbeck

Affiliations

Soon will be listed here.

Abstract

Background: Neuroleptic-induced movement disorders (NIMDs) have overlapping co-morbidity. Earlier studies have described typical clinical movement patterns for individual NIMDs. This study aimed to identify specific movement patterns for each individual NIMD using actometry.

Methods: A naturalistic population of 99 schizophrenia inpatients using conventional antipsychotics and clozapine was evaluated. Subjects with NIMDs were categorized using the criteria for NIMD found in the Diagnostic and Statistical Manual for Mental Disorders - Fourth Edition (DSM-IV).Two blinded raters evaluated the actometric-controlled rest activity data for activity periods, rhythmical activity, frequencies, and highest acceleration peaks. A simple subjective question was formulated to test patient-based evaluation of NIMD.

Results: The patterns of neuroleptic-induced akathisia (NIA) and pseudoakathisia (PsA) were identifiable in actometry with excellent inter-rater reliability. The answers to the subjective question about troubles with movements distinguished NIA patients from other patients rather well. Also actometry had rather good screening performances in distinguishing akathisia from other NIMD. Actometry was not able to reliably detect patterns of neuroleptic-induced parkinsonism and tardive dyskinesia.

Conclusion: The present study showed that pooled NIA and PsA patients had a different pattern in lower limb descriptive actometry than other patients in a non-selected sample. Careful questioning of patients is a useful method of diagnosing NIA in a clinical setting.

Citing Articles

Measuring catatonia motor behavior with objective instrumentation.

von Kanel S, Nadesalingam N, Alexaki D, Gama D, Kyrou A, Lefebvre S Front Psychiatry. 2022; 13:880747.

PMID: 36061273 PMC: 9428315. DOI: 10.3389/fpsyt.2022.880747.

Movement markers of schizophrenia: a detailed analysis of patients' gait patterns.

Martin L, Stein K, Kubera K, Troje N, Fuchs T Eur Arch Psychiatry Clin Neurosci. 2022; 272(7):1347-1364.

PMID: 35362775 PMC: 9508056. DOI: 10.1007/s00406-022-01402-y.

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia.

Kumsa A, Girma S, Alemu B, Agenagnew L Clin Pharmacol. 2020; 12:179-187.

PMID: 33293875 PMC: 7719051. DOI: 10.2147/CPAA.S285585.

Drug-Induced Movement Disorders and Its Associated Factors Among Patients Attending Treatment at Public Hospitals in Eastern Ethiopia.

Misgana T, Yigzaw N, Asfaw G Neuropsychiatr Dis Treat. 2020; 16:1987-1995.

PMID: 32884274 PMC: 7443022. DOI: 10.2147/NDT.S261272.

Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.

Kumsa A, Agenagnew L, Alemu B, Girma S PLoS One. 2020; 15(7):e0235365.

PMID: 32614868 PMC: 7332066. DOI: 10.1371/journal.pone.0235365.

References

Barnes T, McPhillips M . Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. Br J Psychiatry Suppl. 2000; (38):34-43. View

van Harten P, Matroos G, Hoek H, Kahn R . The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I. Schizophr Res. 1996; 19(2-3):195-203. DOI: 10.1016/0920-9964(95)00096-8. View

Cortese L, Caligiuri M, Malla A, Manchanda R, Takhar J, Haricharan R . Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients. Schizophr Res. 2005; 75(1):65-75. DOI: 10.1016/j.schres.2004.08.003. View

Janno S, Holi M, Tuisku K, Wahlbeck K . Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients. Am J Psychiatry. 2004; 161(1):160-3. DOI: 10.1176/appi.ajp.161.1.160. View

Janno S, Holi M, Tuisku K, Wahlbeck K . Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population. BMC Neurol. 2005; 5(1):5. PMC: 555761. DOI: 10.1186/1471-2377-5-5. View

Braude W, Charles I, Barnes T . Coarse, jerky foot tremor: tremographic investigation of an objective sign of acute akathisia. Psychopharmacology (Berl). 1984; 82(1-2):95-101. DOI: 10.1007/BF00426389. View

Lohr J, Caligiuri M . Quantitative instrumental measurement of tardive dyskinesia: a review. Neuropsychopharmacology. 1992; 6(4):231-9. View

HAASE H . The purely neuroleptic effects and its relation to the "neuroleptic threshold". Acta Psychiatr Belg. 1978; 78(1):19-36. View

McCreadie R, Robertson L, Wiles D . The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels. Br J Psychiatry. 1992; 160:793-9. DOI: 10.1192/bjp.160.6.793. View

10.

Krausz M, Moritz S, Naber D, Lambert M, Andresen B . Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia. Eur Psychiatry. 1999; 14(2):84-8. DOI: 10.1016/s0924-9338(99)80722-6. View

11.

Dean C, Russell J, Kuskowski M, Caligiuri M, Nugent S . Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements?. J Clin Psychopharmacol. 2004; 24(3):298-304. DOI: 10.1097/01.jcp.0000125681.97466.e7. View

12.

DENNEY D, Casey D . An objective method for measuring dyskinetic movements in tardive dyskinesia. Electroencephalogr Clin Neurophysiol. 1975; 38(6):645-6. DOI: 10.1016/0013-4694(75)90166-2. View

13.

Cunningham S, Winkelman J, Dorsey C, Lukas S, RICHARDSON G, Sholar M . An electromyographic marker for neuroleptic-induced akathisia: preliminary measures of sensitivity and specificity. Clin Neuropharmacol. 1996; 19(4):321-32. DOI: 10.1097/00002826-199619040-00005. View

14.

BATHIEN N, Koutlidis R, Rondot P . EMG patterns in abnormal involuntary movements induced by neuroleptics. J Neurol Neurosurg Psychiatry. 1984; 47(9):1002-8. PMC: 1028005. DOI: 10.1136/jnnp.47.9.1002. View

15.

Rondot P, BATHIEN N . Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study. Adv Neurol. 1987; 45:361-6. View

16.

Caligiuri M, Tripp R . A portable hand-held device for quantifying and standardizing tremor assessment. J Med Eng Technol. 2004; 28(6):254-62. DOI: 10.1080/03091900410001658111. View

17.

Caligiuri M, Lohr J, Bracha H, Jeste D . Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol Psychiatry. 1991; 29(2):139-48. DOI: 10.1016/0006-3223(91)90042-k. View

18.

Barnes T, Braude W . Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry. 1985; 42(9):874-8. DOI: 10.1001/archpsyc.1985.01790320042006. View

19.

Lipinski J, Hudson J, Cunningham S, Aizley H, Keck Jr P, Mallya G . Polysomnographic characteristics of neuroleptic-induced akathisia. Clin Neuropharmacol. 1991; 14(5):413-9. DOI: 10.1097/00002826-199110000-00004. View

20.

Drake R, Ehrlich J . Suicide attempts associated with akathisia. Am J Psychiatry. 1985; 142(4):499-501. DOI: 10.1176/ajp.142.4.499. View